Tech Company Financing Transactions
MiRagen Therapeutics Funding Round
Amgen Ventures, Atlas Venture and Boulder Ventures participated in a $7 million Series B funding round for MiRagen Therapeutics. The financing was announced by the company on 7/1/2014.
Transaction Overview
Company Name
Announced On
7/1/2014
Transaction Type
Venture Equity
Amount
$7,000,000
Round
Series B
Investors
Proceeds Purpose
Leverone said the extension with Servier is independent of the latest Series B funding installment. That money, he said, will be used to advance MiRagen assets that are not part of the Servier deal.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
6200 Lookout Rd. 100
Boulder, CO 80301
USA
Boulder, CO 80301
USA
Phone
Website
Email Address
Overview
Miragen was founded in 2007 to exploit recent discoveries showing that specific perturbations in microRNA expression are correlated with various forms of cardiovascular disease.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
William Marshall
Chief Financial Officer
Jason Leverone
VP - Bus. Development
Christopher Morl
Browse more venture capital transactions:
Prev: 6/30/2014: Aspire Health venture capital transaction
Next: 7/1/2014: Carterra venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to document all VC transactions involving tech companies. VC investment data records on this site are sourced from publicly available VC deal announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs